Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
暂无分享,去创建一个
P. Lampertico | P. Sarzi-Puttini | R. Caporali | F. Atzeni | A. Batticciotto | M. Covelli | G. Rovera | A. Marchesoni | M. Viganò | R. Pellerito | M. Todoerti | A. Notarnicola | V. Varisco | P. Gibertini